Tolerance to nitroglycerin in vascular smooth muscle cells is not affected by the level of intracellular glutathione or L-cysteine

W. H. Newman, L. M. Zhang, M. H. McDonald, D. J. Jollow, Manuel R Castresana

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

A major hypothesis for the mechanism of tolerance to nitroglycerin (NTG) is that continued use causes a decrease in thiol donors within the vascular smooth muscle cell that are essential for the effect of NTG. We tested this idea directly in the target cell. NTG tolerance, measured as reduced formation of intracellular cyclic guanosine monophosphate (cGMP), was induced in pig coronary smooth muscle cells. The consequence of altering intracellular levels of the thiol donors, glutathione (GSH) and L-cysteine (L-cys), was determined. Incubating cells with 100 μM NTG for 1 h caused an 83% reduction in cGMP formation in response to acute readministration of 200 μM NTG for 2 min but was not associated with a reduction in intracellular GSH or L-cys. This result was not altered when intracellular GSH levels were increased threefold by including 1 mM GSH in the incubation buffer. Also, recovery from tolerance was not affected by supplementation with GSH. Further, the response of cGMP to NTG was not altered by inhibiting the synthesis of GSH and lowering intracellular levels of GSH by 77%. Similar findings were made with supplemental L-cys or N-acetyl-L-cysteine. These results do not support the hypothesis that tolerance to NTG is the result of a reduction of the thiol donors GSH and L-cys within vascular smooth muscle cells.

Original languageEnglish (US)
Pages (from-to)1229-1234
Number of pages6
JournalAnesthesia and Analgesia
Volume81
Issue number6
DOIs
StatePublished - Dec 12 1995
Externally publishedYes

Fingerprint

Nitroglycerin
Vascular Smooth Muscle
Smooth Muscle Myocytes
Glutathione
Cysteine
Cyclic GMP
Sulfhydryl Compounds
Acetylcysteine
Buffers
Swine

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Tolerance to nitroglycerin in vascular smooth muscle cells is not affected by the level of intracellular glutathione or L-cysteine. / Newman, W. H.; Zhang, L. M.; McDonald, M. H.; Jollow, D. J.; Castresana, Manuel R.

In: Anesthesia and Analgesia, Vol. 81, No. 6, 12.12.1995, p. 1229-1234.

Research output: Contribution to journalArticle

@article{e027b544f83e44c58bba7585b6f09ee6,
title = "Tolerance to nitroglycerin in vascular smooth muscle cells is not affected by the level of intracellular glutathione or L-cysteine",
abstract = "A major hypothesis for the mechanism of tolerance to nitroglycerin (NTG) is that continued use causes a decrease in thiol donors within the vascular smooth muscle cell that are essential for the effect of NTG. We tested this idea directly in the target cell. NTG tolerance, measured as reduced formation of intracellular cyclic guanosine monophosphate (cGMP), was induced in pig coronary smooth muscle cells. The consequence of altering intracellular levels of the thiol donors, glutathione (GSH) and L-cysteine (L-cys), was determined. Incubating cells with 100 μM NTG for 1 h caused an 83{\%} reduction in cGMP formation in response to acute readministration of 200 μM NTG for 2 min but was not associated with a reduction in intracellular GSH or L-cys. This result was not altered when intracellular GSH levels were increased threefold by including 1 mM GSH in the incubation buffer. Also, recovery from tolerance was not affected by supplementation with GSH. Further, the response of cGMP to NTG was not altered by inhibiting the synthesis of GSH and lowering intracellular levels of GSH by 77{\%}. Similar findings were made with supplemental L-cys or N-acetyl-L-cysteine. These results do not support the hypothesis that tolerance to NTG is the result of a reduction of the thiol donors GSH and L-cys within vascular smooth muscle cells.",
author = "Newman, {W. H.} and Zhang, {L. M.} and McDonald, {M. H.} and Jollow, {D. J.} and Castresana, {Manuel R}",
year = "1995",
month = "12",
day = "12",
doi = "10.1097/00000539-199512000-00019",
language = "English (US)",
volume = "81",
pages = "1229--1234",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Tolerance to nitroglycerin in vascular smooth muscle cells is not affected by the level of intracellular glutathione or L-cysteine

AU - Newman, W. H.

AU - Zhang, L. M.

AU - McDonald, M. H.

AU - Jollow, D. J.

AU - Castresana, Manuel R

PY - 1995/12/12

Y1 - 1995/12/12

N2 - A major hypothesis for the mechanism of tolerance to nitroglycerin (NTG) is that continued use causes a decrease in thiol donors within the vascular smooth muscle cell that are essential for the effect of NTG. We tested this idea directly in the target cell. NTG tolerance, measured as reduced formation of intracellular cyclic guanosine monophosphate (cGMP), was induced in pig coronary smooth muscle cells. The consequence of altering intracellular levels of the thiol donors, glutathione (GSH) and L-cysteine (L-cys), was determined. Incubating cells with 100 μM NTG for 1 h caused an 83% reduction in cGMP formation in response to acute readministration of 200 μM NTG for 2 min but was not associated with a reduction in intracellular GSH or L-cys. This result was not altered when intracellular GSH levels were increased threefold by including 1 mM GSH in the incubation buffer. Also, recovery from tolerance was not affected by supplementation with GSH. Further, the response of cGMP to NTG was not altered by inhibiting the synthesis of GSH and lowering intracellular levels of GSH by 77%. Similar findings were made with supplemental L-cys or N-acetyl-L-cysteine. These results do not support the hypothesis that tolerance to NTG is the result of a reduction of the thiol donors GSH and L-cys within vascular smooth muscle cells.

AB - A major hypothesis for the mechanism of tolerance to nitroglycerin (NTG) is that continued use causes a decrease in thiol donors within the vascular smooth muscle cell that are essential for the effect of NTG. We tested this idea directly in the target cell. NTG tolerance, measured as reduced formation of intracellular cyclic guanosine monophosphate (cGMP), was induced in pig coronary smooth muscle cells. The consequence of altering intracellular levels of the thiol donors, glutathione (GSH) and L-cysteine (L-cys), was determined. Incubating cells with 100 μM NTG for 1 h caused an 83% reduction in cGMP formation in response to acute readministration of 200 μM NTG for 2 min but was not associated with a reduction in intracellular GSH or L-cys. This result was not altered when intracellular GSH levels were increased threefold by including 1 mM GSH in the incubation buffer. Also, recovery from tolerance was not affected by supplementation with GSH. Further, the response of cGMP to NTG was not altered by inhibiting the synthesis of GSH and lowering intracellular levels of GSH by 77%. Similar findings were made with supplemental L-cys or N-acetyl-L-cysteine. These results do not support the hypothesis that tolerance to NTG is the result of a reduction of the thiol donors GSH and L-cys within vascular smooth muscle cells.

UR - http://www.scopus.com/inward/record.url?scp=0028864861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028864861&partnerID=8YFLogxK

U2 - 10.1097/00000539-199512000-00019

DO - 10.1097/00000539-199512000-00019

M3 - Article

VL - 81

SP - 1229

EP - 1234

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 6

ER -